Related references
Note: Only part of the references are listed.Sustained peripheral depletion of amyloid-β with a novel form of neprilysin does not affect central levels of amyloid-β
Simon J. Henderson et al.
BRAIN (2014)
Characterization of Intermediate Steps in Amyloid Beta (Aβ) Production under Near-native Conditions
Fredrik Olsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
γ-Secretase inhibitors and modulators
Todd E. Golde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
AZ-4217: A High Potency BACE Inhibitor Displaying Acute Central Efficacy in Different In Vivo Models and Reduced Amyloid Deposition in Tg2576 Mice
Susanna Eketjall et al.
JOURNAL OF NEUROSCIENCE (2013)
Presystemic metabolism of AZ'0908, a novel mPGES-1 inhibitor: An in vitro and in vivo cross-species comparison
Johan Bylund et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
γ-Secretase Modulators and Presenilin 1 Mutants Act Differently on Presenilin/γ-Secretase Function to Cleave Aβ42 and Aβ43
Masayasu Okochi et al.
CELL REPORTS (2013)
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
Fredrik Jeppsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain
Ylva Gravenfors et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides
Britt-Marie Swahn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Reducing Available Soluble β-Amyloid Prevents Progression of Cerebral Amyloid Angiopathy in Transgenic Mice
Julia L. Gregory et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Alzheimer's Disease: Presenilin 2-Sparing γ-Secretase Inhibition Is a Tolerable Aβ Peptide-Lowering Strategy
Tomas Borgegard et al.
JOURNAL OF NEUROSCIENCE (2012)
Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
Neha Sehgal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting the Nogo Receptor Complex in Diseases of the Central Nervous System
C. L. McDonald et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
Patrick C. May et al.
JOURNAL OF NEUROSCIENCE (2011)
Sink Hypothesis and Therapeutic Strategies for Attenuating Aβ Levels
Yan Zhang et al.
NEUROSCIENTIST (2011)
Evidence for dimeric BACE-mediated APP processing
Shaobo Jin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid beta-peptide elimination from the brain
Berislav V. Zlokovic et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Alzheimer's disease: strategies for disease modification
Martin Citron
NATURE REVIEWS DRUG DISCOVERY (2010)
Cell biology, regulation and inhibition of β-secretase (BACE-1)
Clare E. Hunt et al.
FEBS JOURNAL (2009)
Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-Brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition
Laura B. Jaeger et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Aβ Immunotherapy: Intracerebral Sequestration of Aβ by an Anti-Aβ Monoclonal Antibody 266 with High Affinity to Soluble Aβ
Kaoru Yamada et al.
JOURNAL OF NEUROSCIENCE (2009)
An amyloid-β protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease
Anna Lord et al.
NEUROBIOLOGY OF DISEASE (2009)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice
Kouhei Nishitomi et al.
JOURNAL OF NEUROCHEMISTRY (2006)
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
R Deane et al.
NATURE MEDICINE (2003)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Share Paper
